Literature DB >> 26974368

Caring for Coronary Artery Disease in China: Managing Modernization.

David Blumenthal1, William Hsiao2, Daniel M Blumenthal3.   

Abstract

Mesh:

Year:  2016        PMID: 26974368     DOI: 10.1001/jamainternmed.2016.0198

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  6 in total

1.  Development of local clinical practice guidelines in the real world: an evolving scene in China.

Authors:  Joey Sw Kwong; Xin Sun
Journal:  Heart Asia       Date:  2017-06-16

2.  Health-promoting Lifestyle in Patients after Percutaneous Coronary Intervention.

Authors:  Ling Xiao; Pan Wang; Qin Fang; Qinghua Zhao
Journal:  Korean Circ J       Date:  2018-06       Impact factor: 3.243

3.  Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age.

Authors:  Jiayin Sun; Wei Han; Sijing Wu; Shuo Jia; Zhenxian Yan; Yonghe Guo; Yingxin Zhao; Yujie Zhou; Wei Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-23       Impact factor: 2.298

4.  Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study.

Authors:  Jiayin Sun; Wei Han; Sijing Wu; Shuo Jia; Zhenxian Yan; Yonghe Guo; Yingxin Zhao; Yujie Zhou; Xiaoli Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-10-09       Impact factor: 2.298

5.  Atherogenic index of plasma is related to coronary atherosclerotic disease in elderly individuals: a cross-sectional study.

Authors:  Haomin Huang; Xiaolong Yu; Lamei Li; Ganwei Shi; Feng Li; Jianqiang Xiao; Zhihua Yun; Gaojun Cai
Journal:  Lipids Health Dis       Date:  2021-07-11       Impact factor: 4.315

6.  The Prognostic Value of a Derived Neutrophil-Lymphocyte Ratio in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Wenjun Fan; Ying Zhang; Xiuxin Gao; Yixiang Liu; Fei Shi; Jingyi Liu; Lixian Sun
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.